Caliper said in a statement it will also make some hires "to accommodate the move of certain functions to the company's Hopkinton headquarters, and to add skill sets which will support the company's strategic direction."
The senior management team has been reorganized, with Anne Kopf-Sill, the current vice president microfluidics R&D becoming vice president molecular diagnostics, and Andrew Chow replacing Kopf-Sill, among other announcements.
Caliper said that the latest reconfiguration is focusing on rationalizing R&D resources. The company aims to reach cash-flow breakeven by the end of 2005.